Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. DOLGIT (ibuprofène)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

DOLGIT (ibuprofène)

Medicine - Posted on Jan 05 2011 - Updated on Jun 12 2019
Active substance (DCI)
  • ibuprofène
history (3)
  • 1/5/11

    DOLGIT (ibuprofène)

    DOLGIT (ibuprofène)
    icône flèche
  • 4/18/07

    DOLGIT (ibuprofène)

    DOLGIT (ibuprofène)
    icône flèche
  • 11/16/05

    DOLGIT 5 POUR CENT, crèmeTube de 50 g (328 856-2)

    DOLGIT 5 POUR CENT, crèmeTube de 50 g (328 856-2)
    icône flèche
Technical information
ATC code
  • M02AA13
Manufacturer
Laboratoire MERCK SERONO
Presentation

DOLGIT 5 %, crème Tube de 50 g - Code CIP : 3288562

All our publications
    Drug therapy Joint and rheumatic diseases Muscular diseases Pain - Inflammation

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
qmxBycbJmxcLTTLx